HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cardiology
Cohort
SGLT2i use linked to lower adherence and QOL in HF patients in cross-sectional MTAC study
Taking More Heart Pills May Actually Feel Better, Not Worse
A cross-sectional study of 78 heart failure patients in a Malaysian MTAC program found SGLT2i users had significantly lower adherence (p = 0…
Heart failure patients taking more heart medicines reported feeling better, not worse, in a new study from Malaysia.
Frontiers
Apr 16, 2026
Cardiology
Cohort
In PH-LHF patients, arrhythmia types predict mortality and rehospitalization, with AT prevalence at 42.2%.
Heart Rhythm Risks in Pulmonary Hypertension
This retrospective cohort study of 1,530 patients with pulmonary hypertension and left heart failure assessed arrhythmia prevalence and pred…
Patients with pulmonary hypertension and heart failure face high risks of dangerous heart rhythm problems that current treatments often miss…
Frontiers
Apr 16, 2026
Cardiology
Cohort
Anemia prevalence is 56.4% in heart failure patients, linked to worse clinical profiles.
Low Iron Could Be Making Heart Failure Worse
A retrospective cohort study of 2,144 adult HF patients in Saudi Arabia found anemia prevalence of 56.4% (95% CI 54.3–58.5%), with moderate …
Low iron is far more common in heart failure than doctors assume, and it tracks closely with how sick the heart actually is.
Frontiers
Apr 16, 2026
Cardiology
Meta-analysis
Axillary IABP support enables ambulation in most heart failure patients with low complication rates.
Heart Pump Patients Can Walk Again Before Transplant
A meta-analysis of four retrospective studies in patients receiving axillary IABP support for heart failure found most patients could ambula…
A new heart pump placement lets dying patients walk while waiting for a transplant, keeping them strong for life-saving surgery.
Frontiers
Apr 15, 2026
Cardiology
Meta-analysis
Meta-analysis shows altered muscle morphology and metabolism in heart failure patients versus healthy controls.
Why Your Muscles Change in Heart Failure
This systematic review and meta-analysis of 35 studies compared cross-sectional muscle morphology and metabolism in patients with heart fail…
Heart failure doesn't just weaken the heart; it silently rewrites the blueprint of your leg muscles to make them less efficient.
Apr 14, 2026
Palliative Care
Cohort
Disability benefit take-up varied by cause of death and geography in England and Wales.
Millions Miss Out on Money Before Death
This retrospective cohort study examined 1,049,493 decedents aged 16 or older in England and Wales with chronic illnesses. Receipt of non-me…
In England and Wales, one out of three people dying from expected causes like cancer or heart disease never receive the financial benefits t…
medRxiv
Apr 14, 2026
Diabetes & Endocrinology
Semaglutide dose linked to lower mortality and cardiovascular risk in patients with baseline CVD
Why Ozempic's Heart Benefits May Have Nothing to Do With Weight Loss
An observational study of 47,199 patients with baseline cardiovascular disease in a U.S. EHR network found higher maximum semaglutide dose w…
A massive real-world study of over 47,000 heart patients suggests that semaglutide may protect the heart through direct biological effects —…
medRxiv
Apr 14, 2026
Cardiology
Plasma proteins linked to HCM severity identified in MYBPC3 carriers and UK Biobank
Could blood proteins predict dangerous heart conditions like sudden cardiac arrest in people with specific gene mutations?
This observational study examined 144 MYBPC3 pathogenic variant carriers and 6,492 UK Biobank participants to identify plasma proteins assoc…
Blood proteins linked to heart failure and sudden cardiac arrest appear in people with specific gene mutations, offering new warning signs f…
medRxiv
Apr 14, 2026
Cardiology
Cohort
CHIP mutations increase cardiovascular risk and mortality in older adults independent of traditional factors.
Your Aging Blood Cells May Be Quietly Attacking Your Heart
This review synthesizes evidence regarding clonal hematopoiesis of indeterminate potential (CHIP) in individuals older than 70 years. Findin…
Aging blood cell mutations called CHIP quietly raise heart attack risk by fueling inflammation, affecting over 10% of adults over 70.
Frontiers
Apr 13, 2026
Genetics & Precision Medicine
Computational platform expands genetic screening scope in high-consanguinity Gulf populations
Could a new genetic screening tool prevent thousands of inherited diseases?
A computational platform description and economic modeling study in Saudi Arabia and Gulf Cooperation Council States projects that expanding…
A new screening tool could prevent 2,800 to 4,200 births of children with inherited diseases each year by expanding checks from two to over …
medRxiv
Apr 13, 2026
Cardiology
RCT
Oral semaglutide reduces composite heart failure outcomes in patients with type 2 diabetes and heart failure history.
A Common Diabetes Pill May Also Protect Your Heart From Failure
This secondary analysis of a phase 3b randomized clinical trial evaluated once-daily oral semaglutide versus placebo in 9,650 participants w…
For millions living with type 2 diabetes and a struggling heart, a medication they might already be taking could offer a powerful, two-in-on…
Apr 11, 2026
Cardiology
Meta-analysis
Mendelian randomization meta-analysis links genetically predicted obesity traits to increased heart failure risk
Fat Risk for Heart Failure Confirmed by DNA
A Mendelian randomization meta-analysis in European and East Asian populations found genetically predicted adult BMI was significantly assoc…
New DNA evidence proves that carrying extra body fat directly causes heart failure, confirming a long-held suspicion with genetic proof.
Frontiers
Apr 10, 2026